HOUSE OF REPRESENTATIVES |
H.B. NO. |
1886 |
THIRTY-FIRST LEGISLATURE, 2022 |
H.D. 1 |
|
STATE OF HAWAII |
|
|
|
|
|
|
||
|
A BILL FOR AN ACT
RELATING TO CONTROLLED SUBSTANCES.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Section 328G-3, Hawaii Revised Statutes, is amended by amending subsection (f) to read as follows:
"(f) No person shall sell, hold, offer, or
distribute for sale any hemp product into which a synthetic cannabinoid has
been added[.] or that contains cannabinoids created through isomerization,
including but not limited to Delta 8 tetrahydrocannabinol."
SECTION 2. Section 329-14, Hawaii Revised Statutes, is amended by amending subsection (g) to read as follows:
"(g)
Any of the following cannabinoids, their
salts, isomers, and salts of isomers, unless specifically excepted, whenever
the existence of these salts, isomers, and salts of isomers is possible within
the specific chemical designation:
(1) Tetrahydrocannabinols; meaning
tetrahydrocannabinols naturally contained in a plant of the genus Cannabis
(cannabis plant), as well as synthetic equivalents of the substances contained
in the plant, or in the resinous extractives of Cannabis, sp. or synthetic
substances, derivatives, and their isomers with similar chemical structure and
pharmacological activity to those substances contained in the plant, such as
the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical
isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; Delta
8 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4
cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature
of these substances is not internationally standardized, compounds of these
structures, regardless of numerical designation of atomic positions, are
covered);
(2) Naphthoylindoles; meaning any compound containing
a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the
indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl
or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the
indole ring to any extent and whether or not substituted in the naphthyl ring
to any extent;
(3) Naphthylmethylindoles; meaning any compound containing
a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the
nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or
2-(4-morpholinyl) ethyl group whether or not further substituted in the indole
ring to any extent and whether or not substituted in the naphthyl ring to any extent;
(4) Naphthoylpyrroles; meaning any compound
containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen
atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or
not further substituted in the pyrrole ring to any extent, whether or not
substituted in the naphthyl ring to any extent;
(5) Naphthylmethylindenes; meaning any compound containing
a naphthylideneindene structure with substitution at the 3-position of the indene
ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or
not further substituted in the indene ring to any extent, whether or not
substituted in the naphthyl ring to any extent;
(6) Phenylacetylindoles; meaning any compound
containing a 3-phenylacetylindole structure with substitution at the nitrogen
atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl
group whether or not further substituted in the indole ring to any extent,
whether or not substituted in the phenyl ring to any extent;
(7) Cyclohexylphenols; meaning any compound
containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the
5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl
group whether or not substituted in the cyclohexyl ring to any extent;
(8) Benzoylindoles; meaning any compound
containing a 3-(benzoyl) indole structure with substitution at the nitrogen
atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl
group whether or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent;
(9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade
name is WIN 55,212-2);
(10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
(Other trade names are: HU-210/HU-211);
(11) Tetramethylcyclopropanoylindoles; meaning any
compound containing a 3-tetramethylcyclopropanoylindole structure with substitution
at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
tetrahydropyranylmethyl group, whether or not further substituted in the indole
ring to any extent and whether or not substituted in the tetramethylcyclopropyl
ring to any extent;
(12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names: APINACA, AKB48);
(13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names: PB-22; QUPIC);
(14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names: 5-fluoro-PB-22; 5F-PB-22);
(15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts, and salts of isomers (Other
names: AB-FUBINACA);
(16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names: ADB-PINACA);
(17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names: AB-CHMINACA);
(18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide,
and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA);
(19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone,
and geometric isomers, salts, and salts of isomers (Other names: THJ-2201);
(20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate,
and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl
2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA,
AMB-FUBINACA);
(21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate,
and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP);
(22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide,
and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl)
analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA);
(23) N-adamantyl-1-fluoropentylindole-3-Carboxamide,
and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA;
5-fluoro-APICA);
(24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate,
and geometric isomers, salts, and salts of isomers (Other names: NM2201);
(25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide,
and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA
and ADB-CHMINACA);
(26) Methyl
2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other
names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and
geometric isomers, salts, and salts of isomers; and
SECTION 3. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 4. This Act shall take effect on January 1, 2222.
Report Title:
Hemp Products; Uniform Controlled Substances Act; Schedule I; Cannabinoids; Delta 8 Tetrahydrocannabinol
Description:
Bans hemp products that contain cannabinoids created through isomerization, including Delta 8 tetrahydrocannabinol. Adds Delta 8 tetrahydrocannabinol to the list of schedule I controlled substances. Effective 1/1/2222. (HD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.